文献速递血脂与心血管预防

QRISK3心血管病风险预测模型在UK Biobank中的独立外部验证

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank.
PubMed 文献 · Heart · 2023-10-26

结果显示QRISK3区分度中等(女性C-statistic 0.722,男性0.697),且随年龄增长下降(65岁及以上者均<0.62),并系统性高估CVD风险,老年参与者高估可达20%。

要点

  • QRISK3在UK Biobank中区分度中等,女性C-statistic 0.722、男性0.697。
  • 65岁及以上参与者区分度均<0.62,模型在老年人群中表现更差。
  • QRISK3系统性高估CVD风险,老年参与者高估可达20%。

核心结论

  • QRISK3在UK Biobank中整体区分度中等,年轻参与者表现最佳。
  • UK Biobank参与者实际CVD风险低于QRISK3预测值,老年参与者尤为明显。
  • 在UK Biobank中需准确预测CVD风险时,可能需要重新校准QRISK3或使用替代模型。

研究设计与样本

  • 纳入无CVD病史且未接受他汀治疗的参与者,结局定义为冠心病、缺血性卒中或短暂性脑缺血发作的首次发生。

主要发现

  • QRISK3在UK Biobank参与者中Harrell's C-statistic女性为0.722、男性为0.697。
  • 所有65岁及以上参与者中QRISK3区分度<0.62。
  • QRISK3系统性高估CVD风险,老年参与者高估可达20%。

临床怎么用

  • 在UK Biobank相关研究中若需准确CVD风险预测,应考虑重新校准QRISK3或选用替代模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To externally evaluate the performance of QRISK3 for predicting 10 year risk of cardiovascular disease (CVD) in the UK Biobank cohort. METHODS: We used data from the UK Biobank, a large-scale prospective cohort study of 403 370 participants aged 40-69 years recruited between 2006 and 2010 in the UK. We included participants with no previous history of CVD or statin treatment and defined the outcome to be the first occurrence of coronary heart disease, ischaemic stroke or transient ischaemic attack, derived from linked hospital inpatient records and death registrations. RESULTS: Our study population included 233 233 women and 170 137 men, with 9295 and 13 028 incident CVD events, respectively. Overall, QRISK3 had moderate discrimination for UK Biobank participants (Harrell's C-statistic 0.722 in women and 0.697 in men) and discrimination declined by age (<0.62 in all participants aged 65 years or older). QRISK3 systematically overpredicted CVD risk in UK Biobank, particularly in older participants, by as much as 20%. CONCLUSIONS: QRISK3 had moderate overall discrimination in UK Biobank, which was best in younger participants. The observed CVD risk for UK Biobank participants was lower than that predicted by QRISK3, particularly for older participants. It may be necessary to recalibrate QRISK3 or use an alternate model in studies that require accurate CVD risk prediction in UK Biobank.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Parsons RE, Liu X, Collister JA, et al. Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank. Heart. 2023. PMID: 37423742. doi:10.1136/heartjnl-2022-321231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。